EGF and Barrett esophagus: Our findings suggest several signaling pathways, including TGF-β, EGF, and their downstream genes as potential targets for further studies aimed at finding biomarkers for early diagnosis, detection and risk prediction in premalignant progression of Barrett’s esophagus.